J. Paul Davignon

A Clinical Trial of Amygdalin (Laetrile) in the Treatment of Human Cancer

Charles G. Moertel, Thomas R. Fleming, Joseph Rubin et al. · New England Journal of Medicine · 1982 · 245 citations

Medicine, Oncology, Pharmacology +14

An intravenous formulation of Δ9-tetrahydrocannabinol using a non-ionic surfactant

James C. Cradock, J. Paul Davignon, Charles L. Litterst et al. · Journal of Pharmacy and Pharmacology · 1973 · 37 citations

Pharmacy, Pharmacology, Toxicology +9

Heroin: Stability and formulation approaches

Guirag Poochikian, James C. Cradock, J. Paul Davignon · International Journal of Pharmaceutics · 1983 · 18 citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +12

EORTC/CRC/NCI guidelines for the formulation of investigational cytotoxic drugs

J. Paul Davignon, J A Slack, Jos H. Beijnen et al. · European Journal of Cancer and Clinical Oncology · 1988 · 18 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Determination of Δ9-tetrahydrocannabinol in pharmaceutical vehicles by high-performance liquid chromatography vehicles by high-performance liquid chromatography

Karl P. Flora, James C. Cradock, J. Paul Davignon · Journal of Chromatography A · 1981 · 15 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +12